The involvement of IL-1β and IL-18 in the development of chronic pain induced by SLE was evident in experiments where spinal topical applications of IL-1β [27] or IL-18 [26] antagonists prolonged the latency of hind paw withdrawal responses to radiant heat stimuli in lupus mice. Here, IL18 is linked to systemic lupus erythematosus.